Free Trial
NASDAQ:CABA

Cabaletta Bio (CABA) Stock Price, News & Analysis

Cabaletta Bio logo
$2.32 -0.12 (-4.92%)
Closing price 04:00 PM Eastern
Extended Trading
$2.36 +0.04 (+1.51%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cabaletta Bio Stock (NASDAQ:CABA)

Advanced

Key Stats

Today's Range
$2.31
$2.46
50-Day Range
$1.33
$2.53
52-Week Range
$0.99
$5.46
Volume
1.62 million shs
Average Volume
2.43 million shs
Market Capitalization
$212.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.50
Consensus Rating
Moderate Buy

Company Overview

Cabaletta Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

CABA MarketRank™: 

Cabaletta Bio scored higher than 52% of companies evaluated by MarketBeat, and ranked 636th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cabaletta Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 7 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Cabaletta Bio has a consensus price target of $14.50, representing about 525.0% upside from its current price of $2.32.

  • Amount of Analyst Coverage

    Cabaletta Bio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cabaletta Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Cabaletta Bio are expected to decrease in the coming year, from ($2.34) to ($2.82) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cabaletta Bio is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cabaletta Bio is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cabaletta Bio has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cabaletta Bio's valuation and earnings.
  • Percentage of Shares Shorted

    6.09% of the outstanding shares of Cabaletta Bio have been sold short.
  • Short Interest Ratio / Days to Cover

    Cabaletta Bio has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cabaletta Bio has recently decreased by 4.30%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cabaletta Bio does not currently pay a dividend.

  • Dividend Growth

    Cabaletta Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.09% of the outstanding shares of Cabaletta Bio have been sold short.
  • Short Interest Ratio / Days to Cover

    Cabaletta Bio has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cabaletta Bio has recently decreased by 4.30%, indicating that investor sentiment is improving.
  • News Sentiment

    Cabaletta Bio has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cabaletta Bio this week, compared to 3 articles on an average week.
  • Search Interest

    32 people have searched for CABA on MarketBeat in the last 30 days. This is an increase of 113% compared to the previous 30 days.
  • MarketBeat Follows

    8 people have added Cabaletta Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cabaletta Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.25% of the stock of Cabaletta Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Cabaletta Bio's insider trading history.
Receive CABA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cabaletta Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CABA Stock News Headlines

Morgan Stanley Keeps Their Buy Rating on Cabaletta Bio (CABA)
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
Cantor Fitzgerald Keeps Their Buy Rating on Cabaletta Bio (CABA)
Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Target Price at $14.50
See More Headlines

CABA Stock Analysis - Frequently Asked Questions

Cabaletta Bio's stock was trading at $2.27 at the beginning of the year. Since then, CABA shares have increased by 2.2% and is now trading at $2.32.

Cabaletta Bio, Inc. (NASDAQ:CABA) announced its earnings results on Thursday, August, 7th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by $0.02.

Cabaletta Bio (CABA) raised $87 million in an initial public offering on Friday, October 25th 2019. The company issued 5,800,000 shares at $14.00-$16.00 per share. Morgan Stanley, Cowen and Company and Evercore Group served as the underwriters for the IPO.

Shares of CABA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cabaletta Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), e.l.f. Beauty (ELF), Jabil (JBL) and Disc Medicine (IRON).

Company Calendar

Last Earnings
8/07/2025
Today
10/07/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CABA
CIK
1759138
Fax
N/A
Employees
50
Year Founded
2017

Price Target and Rating

High Price Target
$25.00
Low Price Target
$3.00
Potential Upside/Downside
+518.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$115.86 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-92.11%
Return on Assets
-74.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.78
Quick Ratio
4.78

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.12 per share
Price / Book
0.75

Miscellaneous

Outstanding Shares
91,465,000
Free Float
81,175,000
Market Cap
$214.49 million
Optionable
Optionable
Beta
3.01

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CABA) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners